Limited Systemic Exposure with Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis

BACKGROUND: Glycopyrronium tosylate (GT; Qbrexza(®) [glycopyrronium] cloth, 2.4%) is a topical anticholinergic approved (USA) for primary axillary hyperhidrosis in patients aged ≥ 9 years. OBJECTIVE: The objective of this study was to compare the pharmacokinetics and safety of GT to oral glycopyrrol...

Descripción completa

Detalles Bibliográficos
Autores principales: Pariser, David M., Lain, Edward L., Mamelok, Richard D., Drew, Janice, Mould, Diane R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113176/
https://www.ncbi.nlm.nih.gov/pubmed/33433785
http://dx.doi.org/10.1007/s40262-020-00975-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113176/
https://www.ncbi.nlm.nih.gov/pubmed/33433785
http://dx.doi.org/10.1007/s40262-020-00975-y

Ejemplares similares